Our Experience in Intraoperative Autologous Blood Salvage in the Pediatric Patients

The development of modern transfusion as a multidisciplinary science, new information about the safety of blood and blood products (hemoproducts), as well as the widespread application of blood and/or hemoproducts (chemotherapy), created the need to develop an alternative to allogeneic blood. The drastic reduction in the number of voluntary blood donors in our country and in the world, led to the need to develop alternative strategies for allogeneic blood transfusion. These alternatives include the use of different strategies autologous transfusion. A retrospective study was conducted in the Department of Cardiothoracic Surgery, Institute for Health Protection of Mother and Child of Serbia "Dr Vukan Cupic" in the last six-years. The results obtained by retrospective analysis of the above data indicate positive therapeutic effect of the application of "Cell Saver" most common in reoperations. The performance of intraoperative "rescue" autologous blood using the "Cell Saver", a track pediatric patients in the perioperative and postoperative period, has an immeasurable significance of teamwork perfuzera, vocational specialist nursing, pediatrician, cardiac surgeon and transfusiology.

Autorentext

O Dr. Bratislav Stankovic trabalha na High Educational School of Professional Health Studies, em Zemun, na Sérvia.